[Transient cardiac enlargement: an unusual adverse event associated with growth hormone therapy].
A 7-year old boy who developed transcient oedemas and cardiac enlargement during the first month of the growth hormone therapy in a dose of 0.7 U/kg/week is described. These symptoms resolved rapidly with the dose reduction. No further adverse events were observed.
Oczkowska
U
U